14 Oct 2017
Enquiry// Mesalazine modified release 500 mg tablets needed in Brazil [ENA00517]
Auramedi, a new Brazilian Pharma Company, an enterprise devoted to bringing to prescribers and customers new concepts related to treatment for health and well being is searching for suppliers of Mesalazine modified release 500 mg tablets for distribution in the country. The current requirement is for 3,000,000 to 5,000,000 tablets per year. The suppliers/manufacturers must support the product with following documents:
1. e-CTD format dossier
2. Certificate of Good Manufacture Practices issued by ANVISA
3. All the requirements to registration in ANVISA.
4. Price submission at CMED (Price Medication Chamber)
Interested suppliers should contact Edson Brito via Email: edson.brito@auramedi.com or Tel: +55 11 95116 8601.
1. e-CTD format dossier
2. Certificate of Good Manufacture Practices issued by ANVISA
3. All the requirements to registration in ANVISA.
4. Price submission at CMED (Price Medication Chamber)
Interested suppliers should contact Edson Brito via Email: edson.brito@auramedi.com or Tel: +55 11 95116 8601.